GlobeImmune resumes Louisville manufacturing
LOUISVILLE — After selling to California-based NantCell Inc., GlobeImmune is restarting operations at its Louisville facility.
The company will be manufacturing at its Louisville facility to support clinical trials for products targeting certain cancers and tumors.
NantCell purchased a controlling interest of GlobeImmune in March for more than $2 million.
SPONSORED CONTENT
Business Cares: April 2024
In Colorado, 1 in 3 women, 1 in 3 men and 1 in 2 transgender individuals will experience an attempted or completed sexual assault in their lifetime. During April, we recognize Sexual Assault Awareness Month with the hopes of increasing conversations about this very important issue.
LOUISVILLE — After selling to California-based NantCell Inc., GlobeImmune is restarting operations at its Louisville facility.
The company will be manufacturing at its Louisville facility to support clinical trials for products targeting certain cancers and tumors.
NantCell purchased a controlling interest of GlobeImmune in March for more than $2 million.
…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
